Journalartikel
Autorenliste: Distler, Joerg H. W.; Strapatsas, Tobias; Huscher, Doerte; Dees, Clara; Akhmetshina, Alfiya; Kiener, Hans P.; Tarner, Ingo H.; Maurer, Britta; Walder, Marcel; Michel, Beat; Gay, Steffen; Smolen, Josef S.; Mueller-Ladner, Ulf; Schett, Georg; Distler, Oliver
Jahr der Veröffentlichung: 2011
Seiten: 1197-1202
Zeitschrift: Annals of the Rheumatic Diseases
Bandnummer: 70
Heftnummer: 7
ISSN: 0003-4967
Open Access Status: Green
DOI Link: https://doi.org/10.1136/ard.2010.140657
Verlag: Elsevier
Objective Vascular disease is common in mixed connective tissue disease (MCTD). The aim of the present study was to investigate, whether dysbalance of angiogenic and angiostatic factors occurs in MCTD. Methods In all, 38 patients with MCTD, and 40 patients with systemic sclerosis (SSc) for comparison, were included. Four centres contributed to this cross-sectional analysis. A total of 66 healthy volunteers were used as controls. The serum levels of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and endostatin were determined by ELISA. For comparisons between controls and patients with MCTD and detection of associations of serum levels with dichotomous clinical parameters in patients with MCTD the Mann-Whitney test was used. Results Serum levels of the angiogenic factor VEGF were significantly elevated in patients with MCTD and SSc. Significantly increased levels of the angiostatic factor endostatin were also detected in MCTD, but not in SSc. No differences were observed for bFGF. Levels of VEGF were higher in patients with MCTD with pulmonary arterial hypertension (PAH), acrosclerosis and myositis. In multivariate linear regression analysis, an additive model of PAH, myositis and lymphadenopathy accounted for 79% of the variability of the VEGF levels (r=0.889). Conclusions Molecular factors modulating angiogenic responses are dysregulated in patients with MCTD and SSc with increases of VEGF in MCTD and SSc and selective upregulation of endostatin in MCTD. Furthermore, high serum levels of VEGF might characterise patients with MCTD with a more severe course of the disease with increased prevalence of PAH and myositis.
Abstract:
Zitierstile
Harvard-Zitierstil: Distler, J., Strapatsas, T., Huscher, D., Dees, C., Akhmetshina, A., Kiener, H., et al. (2011) Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease, Annals of the Rheumatic Diseases, 70(7), pp. 1197-1202. https://doi.org/10.1136/ard.2010.140657
APA-Zitierstil: Distler, J., Strapatsas, T., Huscher, D., Dees, C., Akhmetshina, A., Kiener, H., Tarner, I., Maurer, B., Walder, M., Michel, B., Gay, S., Smolen, J., Mueller-Ladner, U., Schett, G., & Distler, O. (2011). Dysbalance of angiogenic and angiostatic mediators in patients with mixed connective tissue disease. Annals of the Rheumatic Diseases. 70(7), 1197-1202. https://doi.org/10.1136/ard.2010.140657
Schlagwörter
ENDOSTATIN; ENDOTHELIAL GROWTH-FACTOR; RHEUMATIC-DISEASES; SCLERODERMA; SYSTEMIC-SCLEROSIS; vasculogenesis